US healthcare reform is advancing into unchartered territory with healthcare providers migrating from fee-based, volume-driven care to value-based, patient-centered care, ultimately positioning the patient in the center of their approach to care. Ambulatory surgery centers (ASC) in particular, are seeing new opportunities to improve financial performance, while advancing safety and quality of patient care. The rise in minimally invasive surgery is a driving factor for the ASC market, which puts medical devices such as orthopedic, neurosurgery, urology and ophthalmology products at the forefront. Reimbursement for ACS, however, is declining as they face competition from hospitals and outpatient centers. Medical device manufacturers must gain a better understanding of the current healthcare environment and how value based purchasing will ultimately affect product uptake, pricing and reimbursement.
- Key healthcare trends and expectations: Looking forward to 2020
- Entering the next era of healthcare reform: Principles likely to guide reform
- Discuss how industry-wide healthcare and reimbursement trends impact ASCs
- Identify the nine factors that determine reimbursement in a value-based contract
- Explain how the Value-Based Readiness Assessment for ASCs works
Marilyn Denegre-Rumbin JD, MBA
Director, Payor-Reimbursement Strategy and Business Development